Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12107163 | PMC |
| http://dx.doi.org/10.1073/pnas.2506954122 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Stimulant treatment for attention-deficit/hyperactivity disorder and risk of first and repeat juvenile criminal offending: a population-based cohort study.
J Epidemiol Community Health
September 2025
Nepean Medical School, The University of Sydney, Kingswood, New South Wales, Australia
Background: Children and young adults with attention-deficit/hyperactivity disorder (ADHD) may be at increased risk of criminal offending. This study examines the risk of first-time and repeat offending among individuals with ADHD and potential effect of stimulant medication.
Methods: A population-based, data linkage cohort study of individuals born in New South Wales, Australia between 1990 and 2005 and followed until May 2016.
The economic burden of complex CHD in the United States.
Cardiol Young
September 2025
Additional Ventures, Palo Alto, CA, USA.
In the United States, about 1 in 100 children are born with a CHD, with complex cases requiring intensive, lifelong care. Despite medical severity, little data exist on economic burden, driving low impact scores in federal research funding applications, a lack of specific funding appropriations, and minimal research investment. Here, the financial and economic impact was quantified by identifying direct, indirect, and mortality costs of six complex CHDs and compared to two common cardiovascular diseases: coronary heart disease and congestive heart failure.
View Article and Find Full Text PDFPoverty as a Social Determinant of Mental Health Among Young People: Qualitative Findings Across 13 Countries.
J Adolesc Health
September 2025
Sexual, Reproductive, Maternal, Newborn, Child, and Adolescent Health Unit, African Population and Health Research Center, Nairobi, Kenya.
Purpose: Social and economic conditions can have a direct impact on the prevalence and severity of mental health problems across the life course. This study explores adolescents' insights on how poverty as a social determinant influences young people's mental health in 13 countries across the Americas, Africa, Europe and Asia.
Methods: This study uses qualitative data collected through 71 focus group discussions with adolescents aged 12-19 years.
Growth trajectories and risk of overweight and obesity in twins and singletons in the UK and USA: analysis of prospective national cohort data.
Lancet Child Adolesc Health
October 2025
Epidemiology Branch, Division of Population Health Research, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
Background: Twin and singleton growth might be adaptively different to maximise survival in a shared intrauterine environment, translating to smaller average twin birthweight. We aimed to compare growth trajectories and risks of overweight and obesity between twins and singletons.
Methods: We leveraged height, weight, and BMI data from two large and ongoing nationally representative cohorts, the Millennium Cohort Study (MCS) and the National Longitudinal Survey of Youth-Child and Young Adult (NLSY-CYA), that have prospectively collected data from children born in the UK between Sept 1, 2000, and Jan 11, 2002, and participants born in the USA between December, 1970, and January, 2008, respectively, every 2-3 years from birth to adulthood.
Recommendation for use of a long-acting monoclonal antibody to prevent respiratory syncytial virus infection in infants and young children.
Clin Exp Pediatr
September 2025
Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections (LRTIs) in infants and young children. In April 2024, the Korea Ministry of Food and Drug Safety approved nirsevimab (Beyfortus), a long-acting monoclonal antibody, as a passive immunization to prevent RSV-associated LRTI among infants and young children. Nirsevimab was launched in Korea in February 2025.
View Article and Find Full Text PDF